nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—MPO—chronic obstructive pulmonary disease	0.456	1	CbGaD
L-Carnitine—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.193	0.639	CbGbCtD
L-Carnitine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.109	0.361	CbGbCtD
L-Carnitine—SLC25A29—bronchus—chronic obstructive pulmonary disease	0.00365	0.0627	CbGeAlD
L-Carnitine—CROT—bronchus—chronic obstructive pulmonary disease	0.00335	0.0575	CbGeAlD
L-Carnitine—CROT—smooth muscle tissue—chronic obstructive pulmonary disease	0.00327	0.0563	CbGeAlD
L-Carnitine—SLC25A20—connective tissue—chronic obstructive pulmonary disease	0.00311	0.0535	CbGeAlD
L-Carnitine—SLC25A20—bronchus—chronic obstructive pulmonary disease	0.00291	0.0501	CbGeAlD
L-Carnitine—CRAT—bronchus—chronic obstructive pulmonary disease	0.00282	0.0486	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—chronic obstructive pulmonary disease	0.00276	0.0475	CbGeAlD
L-Carnitine—SLC25A20—trachea—chronic obstructive pulmonary disease	0.00261	0.045	CbGeAlD
L-Carnitine—CRAT—trachea—chronic obstructive pulmonary disease	0.00254	0.0436	CbGeAlD
L-Carnitine—Choline—PDE4A—chronic obstructive pulmonary disease	0.00253	1	CrCbGaD
L-Carnitine—CPT1A—connective tissue—chronic obstructive pulmonary disease	0.00245	0.0421	CbGeAlD
L-Carnitine—SLC25A29—lung—chronic obstructive pulmonary disease	0.00235	0.0405	CbGeAlD
L-Carnitine—CPT2—connective tissue—chronic obstructive pulmonary disease	0.00232	0.04	CbGeAlD
L-Carnitine—CPT2—bronchus—chronic obstructive pulmonary disease	0.00217	0.0374	CbGeAlD
L-Carnitine—CROT—lung—chronic obstructive pulmonary disease	0.00216	0.0371	CbGeAlD
L-Carnitine—SLC25A20—lung—chronic obstructive pulmonary disease	0.00188	0.0323	CbGeAlD
L-Carnitine—CRAT—lung—chronic obstructive pulmonary disease	0.00182	0.0313	CbGeAlD
L-Carnitine—CES1—respiratory system—chronic obstructive pulmonary disease	0.00157	0.027	CbGeAlD
L-Carnitine—CPT1A—lung—chronic obstructive pulmonary disease	0.00148	0.0254	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.00143	0.0263	CbGpPWpGaD
L-Carnitine—CPT2—lung—chronic obstructive pulmonary disease	0.0014	0.0241	CbGeAlD
L-Carnitine—CES1—connective tissue—chronic obstructive pulmonary disease	0.00138	0.0237	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—NOS2—chronic obstructive pulmonary disease	0.00133	0.0244	CbGpPWpGaD
L-Carnitine—MPO—respiratory system—chronic obstructive pulmonary disease	0.00131	0.0225	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00125	0.023	CbGpPWpGaD
L-Carnitine—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.0012	0.0206	CbGeAlD
L-Carnitine—MPO—connective tissue—chronic obstructive pulmonary disease	0.00115	0.0198	CbGeAlD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00107	0.0197	CbGpPWpGaD
L-Carnitine—XDH—Effects of Nitric Oxide—NOS3—chronic obstructive pulmonary disease	0.00107	0.0196	CbGpPWpGaD
L-Carnitine—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.000984	0.0169	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000935	0.0172	CbGpPWpGaD
L-Carnitine—SLC22A4—trachea—chronic obstructive pulmonary disease	0.000883	0.0152	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000874	0.016	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—STAT4—chronic obstructive pulmonary disease	0.000871	0.016	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL17A—chronic obstructive pulmonary disease	0.000857	0.0157	CbGpPWpGaD
L-Carnitine—CES1—lung—chronic obstructive pulmonary disease	0.000832	0.0143	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00082	0.015	CbGpPWpGaD
L-Carnitine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000791	0.0136	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000731	0.0134	CbGpPWpGaD
L-Carnitine—MPO—lung—chronic obstructive pulmonary disease	0.000695	0.012	CbGeAlD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000694	0.0127	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000688	0.0126	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000657	0.0121	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000654	0.012	CbGpPWpGaD
L-Carnitine—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000651	0.0112	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000647	0.0119	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000643	0.0118	CbGpPWpGaD
L-Carnitine—SLC22A4—lung—chronic obstructive pulmonary disease	0.000635	0.0109	CbGeAlD
L-Carnitine—CPT1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.000619	0.0114	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000607	0.0111	CbGpPWpGaD
L-Carnitine—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000585	0.0101	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.000571	0.0105	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000556	0.0102	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000556	0.0102	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000498	0.00913	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00046	0.00845	CbGpPWpGaD
L-Carnitine—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00359	CcSEcCtD
L-Carnitine—SLCO1B1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.000456	0.00837	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000456	0.00836	CbGpPWpGaD
L-Carnitine—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00355	CcSEcCtD
L-Carnitine—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00355	CcSEcCtD
L-Carnitine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.00355	CcSEcCtD
L-Carnitine—CROT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000452	0.00829	CbGpPWpGaD
L-Carnitine—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00353	CcSEcCtD
L-Carnitine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00353	CcSEcCtD
L-Carnitine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00353	CcSEcCtD
L-Carnitine—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00352	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—NOS2—chronic obstructive pulmonary disease	0.000447	0.0082	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000446	0.00818	CbGpPWpGaD
L-Carnitine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00348	CcSEcCtD
L-Carnitine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000444	0.00348	CcSEcCtD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000443	0.00813	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00044	0.00807	CbGpPWpGaD
L-Carnitine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000438	0.00343	CcSEcCtD
L-Carnitine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00341	CcSEcCtD
L-Carnitine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.0034	CcSEcCtD
L-Carnitine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00339	CcSEcCtD
L-Carnitine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00338	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000431	0.00792	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.0079	CbGpPWpGaD
L-Carnitine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00337	CcSEcCtD
L-Carnitine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00336	CcSEcCtD
L-Carnitine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00334	CcSEcCtD
L-Carnitine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00332	CcSEcCtD
L-Carnitine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000423	0.00332	CcSEcCtD
L-Carnitine—SLC22A5—lung—chronic obstructive pulmonary disease	0.00042	0.00722	CbGeAlD
L-Carnitine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00329	CcSEcCtD
L-Carnitine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00329	CcSEcCtD
L-Carnitine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00326	CcSEcCtD
L-Carnitine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000409	0.0032	CcSEcCtD
L-Carnitine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.0032	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000407	0.00747	CbGpPWpGaD
L-Carnitine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000407	0.00319	CcSEcCtD
L-Carnitine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000407	0.00319	CcSEcCtD
L-Carnitine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000404	0.00316	CcSEcCtD
L-Carnitine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000403	0.00316	CcSEcCtD
L-Carnitine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000401	0.00314	CcSEcCtD
L-Carnitine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00313	CcSEcCtD
L-Carnitine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00312	CcSEcCtD
L-Carnitine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00308	CcSEcCtD
L-Carnitine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00307	CcSEcCtD
L-Carnitine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00305	CcSEcCtD
L-Carnitine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00305	CcSEcCtD
L-Carnitine—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.00305	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000389	0.00713	CbGpPWpGaD
L-Carnitine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00302	CcSEcCtD
L-Carnitine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00302	CcSEcCtD
L-Carnitine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00302	CcSEcCtD
L-Carnitine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00302	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000384	0.00705	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000384	0.00705	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APIP—chronic obstructive pulmonary disease	0.000384	0.00705	CbGpPWpGaD
L-Carnitine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.003	CcSEcCtD
L-Carnitine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000383	0.003	CcSEcCtD
L-Carnitine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00038	0.00298	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000379	0.00696	CbGpPWpGaD
L-Carnitine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.00294	CcSEcCtD
L-Carnitine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00294	CcSEcCtD
L-Carnitine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00291	CcSEcCtD
L-Carnitine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00288	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00287	CcSEcCtD
L-Carnitine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00285	CcSEcCtD
L-Carnitine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00285	CcSEcCtD
L-Carnitine—CPT1A—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000362	0.00663	CbGpPWpGaD
L-Carnitine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00283	CcSEcCtD
L-Carnitine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00283	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000358	0.00657	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000355	0.00651	CbGpPWpGaD
L-Carnitine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000354	0.00278	CcSEcCtD
L-Carnitine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00276	CcSEcCtD
L-Carnitine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00276	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000351	0.00644	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.00273	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00272	CcSEcCtD
L-Carnitine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00272	CcSEcCtD
L-Carnitine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00272	CcSEcCtD
L-Carnitine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000345	0.0027	CcSEcCtD
L-Carnitine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000344	0.0027	CcSEcCtD
L-Carnitine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00269	CcSEcCtD
L-Carnitine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00269	CcSEcCtD
L-Carnitine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00266	CcSEcCtD
L-Carnitine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00265	CcSEcCtD
L-Carnitine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00265	CcSEcCtD
L-Carnitine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00265	CcSEcCtD
L-Carnitine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00265	CcSEcCtD
L-Carnitine—SLCO1B1—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.000338	0.0062	CbGpPWpGaD
L-Carnitine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00265	CcSEcCtD
L-Carnitine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00265	CcSEcCtD
L-Carnitine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00265	CcSEcCtD
L-Carnitine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00264	CcSEcCtD
L-Carnitine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00264	CcSEcCtD
L-Carnitine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00264	CcSEcCtD
L-Carnitine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.0026	CcSEcCtD
L-Carnitine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000332	0.0026	CcSEcCtD
L-Carnitine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00259	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00258	CcSEcCtD
L-Carnitine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00257	CcSEcCtD
L-Carnitine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00254	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000324	0.00595	CbGpPWpGaD
L-Carnitine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00253	CcSEcCtD
L-Carnitine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00253	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000322	0.00591	CbGpPWpGaD
L-Carnitine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00251	CcSEcCtD
L-Carnitine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00251	CcSEcCtD
L-Carnitine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.0025	CcSEcCtD
L-Carnitine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000318	0.00249	CcSEcCtD
L-Carnitine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00248	CcSEcCtD
L-Carnitine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00248	CcSEcCtD
L-Carnitine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00248	CcSEcCtD
L-Carnitine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.00247	CcSEcCtD
L-Carnitine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00246	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000308	0.00566	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000308	0.00564	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000307	0.00564	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.000306	0.00561	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00559	CbGpPWpGaD
L-Carnitine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00239	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000304	0.00557	CbGpPWpGaD
L-Carnitine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00238	CcSEcCtD
L-Carnitine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00238	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000304	0.00557	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000302	0.00555	CbGpPWpGaD
L-Carnitine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000302	0.00237	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000302	0.00553	CbGpPWpGaD
L-Carnitine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00234	CcSEcCtD
L-Carnitine—CROT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000299	0.00549	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.00548	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.00544	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00544	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00232	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00232	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00232	CcSEcCtD
L-Carnitine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000294	0.0023	CcSEcCtD
L-Carnitine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.0023	CcSEcCtD
L-Carnitine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00229	CcSEcCtD
L-Carnitine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00229	CcSEcCtD
L-Carnitine—CROT—Metabolism—GC—chronic obstructive pulmonary disease	0.000291	0.00534	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000291	0.00534	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.000291	0.00533	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00227	CcSEcCtD
L-Carnitine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00227	CcSEcCtD
L-Carnitine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00227	CcSEcCtD
L-Carnitine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00225	CcSEcCtD
L-Carnitine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00225	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000287	0.00526	CbGpPWpGaD
L-Carnitine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00224	CcSEcCtD
L-Carnitine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00224	CcSEcCtD
L-Carnitine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00224	CcSEcCtD
L-Carnitine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000285	0.00223	CcSEcCtD
L-Carnitine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00222	CcSEcCtD
L-Carnitine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00221	CcSEcCtD
L-Carnitine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00221	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.0022	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00028	0.0022	CcSEcCtD
L-Carnitine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00219	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00219	CcSEcCtD
L-Carnitine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
L-Carnitine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
L-Carnitine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
L-Carnitine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00218	CcSEcCtD
L-Carnitine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00217	CcSEcCtD
L-Carnitine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00216	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00215	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000274	0.00503	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000274	0.00503	CbGpPWpGaD
L-Carnitine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00214	CcSEcCtD
L-Carnitine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00213	CcSEcCtD
L-Carnitine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00213	CcSEcCtD
L-Carnitine—CROT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000271	0.00497	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000271	0.00496	CbGpPWpGaD
L-Carnitine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00211	CcSEcCtD
L-Carnitine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00211	CcSEcCtD
L-Carnitine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00211	CcSEcCtD
L-Carnitine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.00209	CcSEcCtD
L-Carnitine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00209	CcSEcCtD
L-Carnitine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00209	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00208	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00208	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00207	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000263	0.00483	CbGpPWpGaD
L-Carnitine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00205	CcSEcCtD
L-Carnitine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00205	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000262	0.00481	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00204	CcSEcCtD
L-Carnitine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00201	CcSEcCtD
L-Carnitine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00201	CcSEcCtD
L-Carnitine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00201	CcSEcCtD
L-Carnitine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00201	CcSEcCtD
L-Carnitine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.002	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000254	0.00467	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000254	0.00467	CbGpPWpGaD
L-Carnitine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00199	CcSEcCtD
L-Carnitine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00199	CcSEcCtD
L-Carnitine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00199	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00463	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00463	CbGpPWpGaD
L-Carnitine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.00198	CcSEcCtD
L-Carnitine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00197	CcSEcCtD
L-Carnitine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00197	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00196	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00195	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000248	0.00455	CbGpPWpGaD
L-Carnitine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00194	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—GC—chronic obstructive pulmonary disease	0.000248	0.00454	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000248	0.00454	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GC—chronic obstructive pulmonary disease	0.000248	0.00454	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000245	0.0045	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000243	0.00446	CbGpPWpGaD
L-Carnitine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.0019	CcSEcCtD
L-Carnitine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.0019	CcSEcCtD
L-Carnitine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00187	CcSEcCtD
L-Carnitine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00187	CcSEcCtD
L-Carnitine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00187	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000237	0.00435	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000237	0.00434	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000236	0.00434	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000235	0.00431	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00184	CcSEcCtD
L-Carnitine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00183	CcSEcCtD
L-Carnitine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00183	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000231	0.00423	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00023	0.00422	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00023	0.00422	CbGpPWpGaD
L-Carnitine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00023	0.0018	CcSEcCtD
L-Carnitine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.0018	CcSEcCtD
L-Carnitine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0018	CcSEcCtD
L-Carnitine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00179	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000228	0.00419	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000228	0.00417	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00177	CcSEcCtD
L-Carnitine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00176	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000224	0.00412	CbGpPWpGaD
L-Carnitine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00174	CcSEcCtD
L-Carnitine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00174	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—chronic obstructive pulmonary disease	0.000222	0.00407	CbGpPWpGaD
L-Carnitine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.00173	CcSEcCtD
L-Carnitine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00172	CcSEcCtD
L-Carnitine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00171	CcSEcCtD
L-Carnitine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.0017	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000216	0.00396	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000215	0.00395	CbGpPWpGaD
L-Carnitine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00168	CcSEcCtD
L-Carnitine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00168	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000214	0.00393	CbGpPWpGaD
L-Carnitine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00165	CcSEcCtD
L-Carnitine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00164	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000209	0.00384	CbGpPWpGaD
L-Carnitine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00162	CcSEcCtD
L-Carnitine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00162	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000206	0.00379	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.00377	CbGpPWpGaD
L-Carnitine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0016	CcSEcCtD
L-Carnitine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0016	CcSEcCtD
L-Carnitine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0016	CcSEcCtD
L-Carnitine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0016	CcSEcCtD
L-Carnitine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000205	0.0016	CcSEcCtD
L-Carnitine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00159	CcSEcCtD
L-Carnitine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00159	CcSEcCtD
L-Carnitine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00159	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000203	0.00373	CbGpPWpGaD
L-Carnitine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00159	CcSEcCtD
L-Carnitine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00158	CcSEcCtD
L-Carnitine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00157	CcSEcCtD
L-Carnitine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00157	CcSEcCtD
L-Carnitine—Depression—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00157	CcSEcCtD
L-Carnitine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00156	CcSEcCtD
L-Carnitine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00153	CcSEcCtD
L-Carnitine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00152	CcSEcCtD
L-Carnitine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
L-Carnitine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
L-Carnitine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
L-Carnitine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000192	0.00353	CbGpPWpGaD
L-Carnitine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00151	CcSEcCtD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00019	0.00349	CbGpPWpGaD
L-Carnitine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00148	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000188	0.00345	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000188	0.00345	CbGpPWpGaD
L-Carnitine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00146	CcSEcCtD
L-Carnitine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00146	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000184	0.00337	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00336	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00336	CbGpPWpGaD
L-Carnitine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00143	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00142	CcSEcCtD
L-Carnitine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00141	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000179	0.00328	CbGpPWpGaD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000177	0.00324	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000176	0.00324	CbGpPWpGaD
L-Carnitine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00134	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000172	0.00315	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000172	0.00315	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000169	0.0031	CbGpPWpGaD
L-Carnitine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00132	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000164	0.00302	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000164	0.00301	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000164	0.00301	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000163	0.003	CbGpPWpGaD
L-Carnitine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00128	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00298	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000161	0.00295	CbGpPWpGaD
L-Carnitine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00126	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GC—chronic obstructive pulmonary disease	0.00016	0.00293	CbGpPWpGaD
L-Carnitine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00125	CcSEcCtD
L-Carnitine—CROT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000159	0.00292	CbGpPWpGaD
L-Carnitine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00124	CcSEcCtD
L-Carnitine—CROT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000157	0.00288	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000157	0.00288	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000157	0.00287	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000153	0.0028	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000152	0.00279	CbGpPWpGaD
L-Carnitine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00118	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000148	0.00272	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000147	0.00269	CbGpPWpGaD
L-Carnitine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00113	CcSEcCtD
L-Carnitine—CROT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000143	0.00263	CbGpPWpGaD
L-Carnitine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000141	0.0011	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00014	0.00256	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00014	0.00256	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000138	0.00254	CbGpPWpGaD
L-Carnitine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00106	CcSEcCtD
L-Carnitine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00106	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000135	0.00248	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000135	0.00248	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000134	0.00245	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000134	0.00245	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000134	0.00245	CbGpPWpGaD
L-Carnitine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00104	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000133	0.00244	CbGpPWpGaD
L-Carnitine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00104	CcSEcCtD
L-Carnitine—CROT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00242	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00102	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000128	0.00235	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000128	0.00234	CbGpPWpGaD
L-Carnitine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000995	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000977	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000125	0.00229	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000125	0.00229	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000123	0.00226	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000122	0.00224	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000122	0.00224	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000122	0.00224	CbGpPWpGaD
L-Carnitine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000955	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00217	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000912	CcSEcCtD
L-Carnitine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000911	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000906	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000899	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000114	0.00209	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APIP—chronic obstructive pulmonary disease	0.000114	0.00209	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00207	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000113	0.00207	CbGpPWpGaD
L-Carnitine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000881	CcSEcCtD
L-Carnitine—CRAT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000871	CcSEcCtD
L-Carnitine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000869	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000111	0.00204	CbGpPWpGaD
L-Carnitine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000868	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—GC—chronic obstructive pulmonary disease	0.000111	0.00203	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00202	CbGpPWpGaD
L-Carnitine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000863	CcSEcCtD
L-Carnitine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000856	CcSEcCtD
L-Carnitine—CROT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000109	0.00199	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000108	0.00198	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000819	CcSEcCtD
L-Carnitine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000819	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000103	0.00189	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00186	CbGpPWpGaD
L-Carnitine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000792	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000792	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.7e-05	0.00178	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.66e-05	0.00177	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.6e-05	0.00176	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.000738	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.37e-05	0.00172	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.37e-05	0.00172	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.26e-05	0.0017	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.24e-05	0.0017	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.24e-05	0.0017	CbGpPWpGaD
L-Carnitine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000718	CcSEcCtD
L-Carnitine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000708	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	8.95e-05	0.00164	CbGpPWpGaD
L-Carnitine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000685	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.71e-05	0.0016	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.66e-05	0.00159	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.61e-05	0.00158	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.61e-05	0.00158	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.61e-05	0.00158	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.52e-05	0.00156	CbGpPWpGaD
L-Carnitine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.45e-05	0.000662	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.19e-05	0.0015	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.17e-05	0.0015	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.17e-05	0.0015	CbGpPWpGaD
L-Carnitine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000637	CcSEcCtD
L-Carnitine—Rash—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000631	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000631	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.03e-05	0.00147	CbGpPWpGaD
L-Carnitine—Headache—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000627	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.86e-05	0.00144	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.82e-05	0.00144	CbGpPWpGaD
L-Carnitine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000595	CcSEcCtD
L-Carnitine—XDH—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.53e-05	0.00138	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.47e-05	0.00137	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GC—chronic obstructive pulmonary disease	7.32e-05	0.00134	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.24e-05	0.00133	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.04e-05	0.00129	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.81e-05	0.00125	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	6.66e-05	0.00122	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—chronic obstructive pulmonary disease	6.53e-05	0.0012	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NOS3—chronic obstructive pulmonary disease	6.24e-05	0.00115	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	6.1e-05	0.00112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.04e-05	0.00111	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.04e-05	0.00111	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	5.98e-05	0.0011	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GCLC—chronic obstructive pulmonary disease	5.97e-05	0.0011	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.96e-05	0.00109	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.95e-05	0.00109	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.57e-05	0.00102	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-05	0.00102	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-05	0.00102	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.55e-05	0.00102	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CTGF—chronic obstructive pulmonary disease	5.45e-05	0.001	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-05	0.000974	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-05	0.000974	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.29e-05	0.00097	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.26e-05	0.000965	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.02e-05	0.000921	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.78e-05	0.000877	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.48e-05	0.000821	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.27e-05	0.000783	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.19e-05	0.000768	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.13e-05	0.000758	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.05e-05	0.000743	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—chronic obstructive pulmonary disease	4e-05	0.000734	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.96e-05	0.000727	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GCLC—chronic obstructive pulmonary disease	3.95e-05	0.000726	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.93e-05	0.000721	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.85e-05	0.000707	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.85e-05	0.000706	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.000669	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.63e-05	0.000666	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CTGF—chronic obstructive pulmonary disease	3.61e-05	0.000662	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.58e-05	0.000657	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000656	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000656	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.42e-05	0.000628	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.33e-05	0.00061	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.07e-05	0.000564	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.86e-05	0.000524	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.77e-05	0.000509	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.74e-05	0.000502	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.69e-05	0.000493	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.55e-05	0.000468	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000455	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.43e-05	0.000446	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.000443	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.37e-05	0.000435	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.11e-05	0.000386	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.08e-05	0.000382	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.94e-05	0.000356	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000348	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000339	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000321	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000301	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000288	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.46e-05	0.000268	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.44e-05	0.000264	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.34e-05	0.000246	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000233	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.64e-06	0.000159	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.27e-06	0.000152	CbGpPWpGaD
